BioAge Labs (BIOA) Interest & Investment Income (2023 - 2026)

BioAge Labs has disclosed Interest & Investment Income across 4 years of filings, most recently posting $3.3 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $3.3 million, down 12.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.6 million (up 4.92% YoY), and the FY2025 annual result was $13.1 million, up 35.9% from the prior year.
• Interest & Investment Income came in at $3.3 million for Q1 2026 at BioAge Labs, up from $2.8 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $4.1 million in Q4 2024 to a low of $379000.0 in Q4 2023.
• The 4-year median for Interest & Investment Income is $2.8 million (2025), against an average of $2.4 million.
• Across the five-year window, Interest & Investment Income surged 980.47% in 2024 and slumped 31.82% in 2025, its largest moves.
• BioAge Labs' Interest & Investment Income stood at $379000.0 in 2023, then soared by 980.47% to $4.1 million in 2024, then plunged by 31.82% to $2.8 million in 2025, then grew by 17.05% to $3.3 million in 2026.
• The last three Interest & Investment Income figures came in at $3.3 million (Q1 2026), $2.8 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.